Drugs for Hemopericardium (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 50)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Colchicine |
Approved |
Phase 4 |
|
64-86-8 |
2833 6167 |
Synonyms:
(S)-N-(5,6,7,9-TETRAHYDRO-1,2,3,10-TETRAMETHOXY-9-OXOBENZO[A]HEPTALEN-7-YL)ACETAMIDE
BENZO(A)HEPTALEN-9(5H)-ONE
Colchicin
Colchicina
COLCHICINE
Colchicinum
COLCRYS
Colcrys®|methoxylated analogue of XD1|XD25
COLGOUT
|
COLSALOID
CONDYLON
GLOPERBA
MITIGARE
N-(1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDROBENZO[A]HEPTALEN-7-YL)ACETAMIDE
N-(5,6,7,9-TETRAHYDRO-1,2,3,10-TETRAMETHOXY-9-OXOBENZO[A]HEPTALEN-7-YL)ACETAMIDE
N-ACETYLTRIMETHYLCOLCHICINIC ACID METHYL ETHER
NSC-757
|
|
2 |
|
Diclofenac |
Approved, Vet_approved |
Phase 4 |
|
15307-86-5, 15307-79-6 |
3033 |
Synonyms:
[2-(2,6-Dichloroanilino)phenyl]acetate
[2-(2,6-Dichloroanilino)phenyl]acetic acid
2-((2,6-Dichlorophenyl)amino)benzeneacetate
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-[(2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
ACOFLAM
ACOFLAM RET
ACOFLAM SR
Allvoran
Apo-Diclo
ARTHRONAC
ARTHROTEC
ARTHROTEC 50
ARTHROTEC 75
Assaren
Benfofen
CAMBIA
CAT458
CATAFLAM
Cataflam®|CGP-45840B|GP-45840|Voltaren®|Voltarol®
CGP-45840B
CLOSTERIL 100
DEFANAC
DEFANAC RETARD
DEFANAC SR
Delphimix
DEXOMON RET
DEXOMON SR
Dichlofenac
Dichlofenal
Dichronic
Diclobenin
Diclofenac
Diclofenac acid
Diclofenac potassium
DICLOFENAC SOD
Diclofenac sodium
DICLOFENAC SODIUM SALT
Diclofenac, sodium
Diclofenaco
Diclofenacum
Diclofenamate
Diclofenamic acid
DICLOFLEX
DICLOFLEX RET
DICLOFLEX SR
DICLOMAX RET
DICLOMAX SR
Diclonate p
Diclophenac
Diclo-Phlogont
Diclo-Puren
Diclord
Dicloreum
DICLOTARD 100 MR
DICLOTARD 75 MR
DICLOVOL
DICLOVOL RET
DICLOVOL SR
DICLOZIP 25
DICLOZIP 50
Dicrofenac
DIFENOR XL
DIGENAC XL 100
Dolobasan
DSG318
Duravolten
DYLOJECT
Ecofenac
ECONAC
ECONAC SR
ECONAC XL
Effekton
ENSTAR SR
ENSTAR XL
ENZED
Feloran
FENACTOL
FENACTOL RET
|
FENACTOL SR
FLAMATAK MR
FLAMRASE
FLAMRASE SR
FLEXOTARD MR
GP-45840
ISCLOFEN
ISV-205
Kriplex
LOFENSAID 25
LOFENSAID 50
LOFENSAID RET 100
LOFENSAID RET 75
MASIDEMEN
MISOFEN
MOBIGEL
MOBIGEL PAINEZE
MOTIFENE
Neriodin
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Orthofen
Orthophen
Ortofen
PENNSAID
Primofenac
Prophenatin
ProSorb-D
RHEUMATAC RET 75
RHUMALGAN
RHUMALGAN CR 100
RHUMALGAN CR 75
RHUMALGAN SR
RHUMALGAN XL
SLOFENAC
Sodium diclofenac
Solaraze
Solaraze T
SR 38
SR-38
Tsudohmin
VALDIC 100 RET
VALDIC 75 RET
VALENAC
Valetan
VOL458
Voldal
VOLRAMAN
VOLSAID RET 100
VOLSAID RET 75
Voltaren
VOLTAREN EMULGEL
Voltaren Ophtha
VOLTAREN OPHTHALMIC
Voltaren Rapide
VOLTAREN RET
Voltaren SR
VOLTAREN XR
VOLTARENE
VOLTARENE EMULGEL
VOLTARENE L.P.
VOLTARENE RET
VOLTAREN-XR
Voltarol
VOLTAROL 12 HOUR EMULGEL P
VOLTAROL ACTIVE
VOLTAROL EMULGEL
VOLTAROL EMULGEL P
VOLTAROL GEL PATCH
VOLTAROL OPHTHA
VOLTAROL PAIN-EZE EMULGEL
VOLTAROL RET
VOLTAROL SR
Xenid
Zorvolex
ZORVOLEX CAPSULES
|
|
3 |
|
Bupivacaine |
Approved, Investigational |
Phase 4 |
|
2180-92-9, 38396-39-3 |
2474 |
Synonyms:
(+-)-Bupivacaine
(±)-bupivacaine
(RS)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
Abbott brand OF bupivacaine hydrochloride
ANEKAIN
Anhydrous, bupivacaine
Astra brand OF bupivacaine hydrochloride
AstraZeneca brand OF bupivacaine hydrochloride
Aventis brand OF bupivacaine hydrochloride
Bloqueina
Braun brand OF bupivacaine hydrochloride
Braun, bupivacaina
Bucaine
Bupivacain janapharm
Bupivacain RPR
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaina braun
BUPIVACAINE
Bupivacaine anhydrous
Bupivacaine carbonate
Bupivacaine HCL
Bupivacaine HCL kit
Bupivacaine hydrochloride
Bupivacaine monohydrochloride, monohydrate
Bupivacain-RPR
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
Buvacaina
|
Carbonate, bupivacaine
Carbostesin
CBupivacaine
Chirocaine
DepoBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
DL-Bupivacaine|Exparel®|Marcain®|Posimir®|Sensorcaine®|W-7|Xaracoll®
Dolanaest
DUR-843
Exparel
Hydrochloride, bupivacaine
Inibsa brand OF bupivacaine hydrochloride
Janapharm, bupivacain
Jenapharm brand OF bupivacaine hydrochloride
LAC-43
LIQ865
LIQ-865
Marcain
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
Pisa brand OF bupivacaine hydrochloride
Racemic bupivacaine
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
SKY-0402
Strathmann brand OF bupivacaine hydrochloride
Svedocain sin vasoconstr
Transdur-Bupivacaine
|
|
4 |
|
Cisatracurium |
Approved, Investigational |
Phase 4 |
|
96946-41-7 |
62887 |
Synonyms:
(1r,2r,1'r,2'r)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
(1R,2R,1'r,2'r)-Atracurium
(1R-cis,1'r-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
(1R-cis,1'r-cis)-Atracurium
CISATRACURIUM
|
Cisatracurium besilate
Cisatracurium besylate
Cisatracurium cation
Cisatracurium ion
Nimbex
|
|
5 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676 |
Synonyms:
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
a-Diethylamino-2,6-dimethylacetanilide
ALGRX 3268
ALGRX-3268
ALPHACAINE
alpha-Diethylamino-2,6-dimethylacetanilide
ANESTACON
Astrazeneca brand OF lidocaine
Dalcaine
Dentipatch
Dilocaine
EMBOLEX
IONTOCAINE
Jenapharm brand OF lidocanine hydrochloride
L-Caine
Lidocaina
Lidocaína
LIDOCAINE
Lidocaine carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
|
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
LIDOCATON
Lidoderm
LIDOPEN
Lignocaine
LIGNOCAINE HCL
LIGNOSTAB
LMX 4
Novocol brand OF lidocaine hydrochloride
NSC-40030
Octocaine
ORAQIX
Strathmann brand OF lidocaine hydrochloride
VAGISIL
Xylesthesin
Xylocaine
Xylocaine®
Xylocitin
XYLODASE
Xyloneural
XYLOTOX
ZTLIDO
Α-diethylamino-2,6-dimethylacetanilide
|
|
6 |
|
Dexamethasone acetate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
1177-87-3 |
3680 |
Synonyms:
16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate
2-{1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl}-2-oxoethyl acetic acid
9alpha-Fluoro-16alpha-methylprednisolone acetate
DECADRON-LA
Dexamethasone 21-acetate
|
DEXAMETHASONE ACETATE
Dexamethasone acetate anhydrous
Dexamethasone acetate, anhydrous
Dexamethasone acetic acid
Dexamethasoni acetas
|
|
7 |
|
Dexamethasone |
Approved, Investigational, Vet_approved |
Phase 4 |
|
50-02-2 |
3003 5743 |
Synonyms:
[<sup>3</sup>H]-dexamethasone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16a-Methyl-9a-fluoro-1-dehydrocortisol
16Α-methyl-9α-fluoro-1-dehydrocortisol
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16a-methyl-9a-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
9a-Fluoro-16a-methylprednisolone
9a-Fluoro-16BETA-methylprednisolone
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-Fluoro-16alpha-methyl-prednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9Α-fluoro-16α-methylprednisolone
Adexone
Aeroseb-D
Aeroseb-dex
Ak dex OPH otic soln 0.1%
Alcon brand OF dexamethasone
alpha -Fluoro-16-alpha -methylcortisol
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (veterinary)
Bisu DS
Calonat
Corson
Corsone
Cortisumman
DALALONE
Decacort
Decacortin
Decaderm
Decadron
Decadron Tablets, Elixir
Decadron®|desametasone|fluormethylprednisolone
DECADRON-75
DECADRON-LA
Decagel
Decaject
Decaject l.a.
Decaject-l.a.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
DEX
DEXA
Dexa mamallet
DEXACEN-4
Dexacidin
Dexacort
Dexacortal
Dexa-cortidelt
Dexacortin
Dexa-cortisyl
DEXACORTISYL
Dexadeltone
Dexafarma
DEXAFREE
DEXAIR
Dexalona
Dexaltin
Dexa-Mamallet
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
DEXAMETHASONE
Dexaméthasone
Dexamethasone acetate
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
DEXAMETHASONE METASULFOBENZOATE SODIUM
DEXAMETHASONE PALMITATE
Dexamethasone sodium phosphate
|
DEXAMETHASONE VALERATE
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexa-scheroson
Dexa-sine
Dexason
Dexasone
Dexasone 0.5MG
Dexasone 0.75MG
Dexasone 4MG
Dexasporin
Dex-ide
Dexinolon
Dexinoral
Dexone
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
Dexonium
Dexpak
DEXSOL
Dextelan
DEXTENZA
DEXYCU KIT
Dezone
Dinormon
DROPODEX
DXM
DXM833
DXMS
ECR brand OF dexamethasone
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy brand OF dexamethasone
Gammacorten
GPPE EAR SPY
Hexadecadrol
Hexadrol
Hexadrol elixir
Hexadrol Tablets
HL-Dex
ICN brand OF dexamethasone
IontoDex
Isopto-dex
ISV-305
KORTICO INJECTION
Lokalison F
Loverine
Luxazone
MARTAPAN
Maxidex
Maxidex ont 0.1%
Maxidex sus 0.1%
Maxitrol
Mediamethasone
Merck brand OF dexamethasone
Merz brand 1 OF dexamethasone
Merz brand 2 OF dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
Mymethasone
Naquasone (veterinary)
NEODECADRON
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
NSC 34521
NSC-34521
Ocu-trol
Oradexon
OTO-104
OTOMIZE
OZURDEX
Pet derm III
Pet-Derm Iii
PHL-Dexamethasone
PMS Dexamethasone elixir 0.5mg/5ML
PMS-Dexamethasone
Policort
Posurdex
Prednisolon F
Prednisolone F
Prodex
Sandoz dexamethasone
SK-Dexamethasone
SOFRADEX
SPERSADEX COMP
Spoloven
Sunia sol D
Superprednol
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
Visumetazone
|
|
8 |
|
Neostigmine |
Approved, Vet_approved |
Phase 4 |
|
59-99-4 |
4456 5824 |
Synonyms:
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamic acid
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYL-AMMONIUM
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYLAZANIUM
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYL-AZANIUM
[3-[DIMETHYLAMINO(OXO)METHOXY]PHENYL]-TRIMETHYLAMMONIUM
3-Trimethylammoniumphenyl N,N-dimethylcarbamate
3-Trimethylammoniumphenyl N,N-dimethylcarbamic acid
BLOXIVERZ
Bromide, neostigmine
Eustigmin
Eustigmine
Methylsulfate, neostigmine
m-Trimethylammoniumphenyldimethylcarbamate
m-Trimethylammoniumphenyldimethylcarbamic acid
Neostigmina
NEOSTIGMINE
|
Neostigmine bromide
NEOSTIGMINE METHYL SULFATE
Neostigmine methylsulfate
NEOSTIGMINE METILSULFATE
NSC-93753
Polstigmine
Proserine
Prostigmin
PROSTIGMIN (TN)
Prostigmin®
Prostigmine
Prozerin
ROBINUL-NEOSTIG
Synstigmin
Syntostigmine
Vagostigmine
|
|
9 |
|
Isoflurane |
Approved, Vet_approved |
Phase 4 |
|
26675-46-7 |
3763 |
Synonyms:
1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether
Aerrane
COMPOUND 469
COMPOUND-469
Ethane
Forane
Forane®
|
Forene
HCFE-235DA2
Isoflurane
Isoflurane [Usan:Ban:Inn:Jan]
Isoflurano
Isofluranum
Isofluranum [INN-Latin]
|
|
10 |
|
Ranitidine |
Approved, Withdrawn |
Phase 4 |
|
66357-59-3, 82530-72-1, 66357-35-5 |
3001055 5039 |
Synonyms:
(e)-Ranitidine
1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulphanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
a-(2-Dimethylaminoethoxy)diphenylmethane
Achedos
Acidex
AH-19065|Gavilast®|GR-122311X|Zantac®
Alledryl
Allerdryl
Allergan
Allergina
alpha-(2-Dimethylaminoethoxy)diphenylmethane
Atural
Axoban
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
Benadryl
Bendylate
Benhydramin
Benylin
Benzantin
Benzhydramine
beta-Dimethylaminoethanol diphenylmethyl ether
beta-Dimethylaminoethyl benzhydryl ether
Biotidin
Citrate, diphenhydramine
Coralen
Curan
Difenhidramina
Difenhydramine
Dimedrol
Dimedrolum
Dimethyl[(5-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulphanyl]methyl}furan-2-yl)methyl]amine
Dimethylamine benzhydryl ester
Diphamine
Diphantine
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
Diphenhydramine hydrochloride
Diphenhydraminum
Diphenylhydramin
Diphenylhydramine
Dobacen
Dormin
Duractin
Ezopta
Gastrial
Gastrosedol
Hydrochloride, diphenhydramine
Hydrochloride, ranitidine
Istomar
|
Logast
Mauran
Microtid
N (2-(((5-((dimethylamino)Methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
O-Benzhydryldimethylaminoethanol
Ptinolin
Quantor
Quicran
Radinat
RAN
Randin
Ranidine
Ranin
Raniogas
Ranisen
Raniter
Ranitidin
Ranitidina
Ranitidine
Ranitidine (form I and form II)
Ranitidine base
Ranitidine HCL 1/2 type
Ranitidine hydrochloride
Ranitidinum
Ranitiget
Rantacid
Rantidine
Ratic
Raticina
Restamin
RND
Sampep
Sostril
Taural
Tritec
Ulceranin
Ul-pep
Urantac
Verlost
Vesyca
Vizerul
Weichilin
Weidos
Xanidine
Zantab
Zantac
Zantadin
Zantic
Α-(2-dimethylaminoethoxy)diphenylmethane
Î’-dimethylaminoethanol diphenylmethyl ether
Î’-dimethylaminoethyl benzhydryl ether
|
|
11 |
|
Metoclopramide |
Approved, Investigational |
Phase 4 |
|
364-62-5 |
4168 |
Synonyms:
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
4-Amino-5-chloro-2-methoxy-N-(b-diethylaminoethyl)benzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-2-methoxy-N-(β-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-O-anisamide
4-AMINO-5-CHLORO-N-(2-DIETHYLAMINOETHYL)-2-METHOXYBENZAMIDE
4-AMINO-5-CHLORO-N-(2-DIETHYLAMINOETHYL)-2-METHOXY-BENZAMIDE
4-AZANYL-5-CHLORANYL-N-(2-DIETHYLAMINOETHYL)-2-METHOXY-BENZAMIDE
Apo-Metoclop
Berk brand OF metoclopramide hydrochloride
Cerucal
CLOPRA
CLOPRA-"YELLOW"
Clopra-Yellow
Clopromate
DEL
Dihydrochloride, metoclopramide
Duraclamid
Elieten
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
Gastro-Timelets
Gimoti® (metoclopramide nasal spray)|metaclopromide|methochlopramide|metochlopramide|metoclopramide hydrochloride|Reglan®
Hydrochloride, metoclopramide
Imperan
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
|
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
METOCLOPRAMIDE
Metoclopramide dihydrochloride
Metoclopramide Hcl
Metoclopramide hydrochloride
Metoclopramide Intensol
Metoclopramide monohydrochloride
Metoclopramide monohydrochloride, monohydrate
Metoclopramide Omega
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metramid
Monohydrochloride, metoclopramide
Moriperan
Mygdalon
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Primperan
Reclomide
Reglan
Reliveran
Rimetin
Temmler brand OF metoclopramide hydrochloride
Terperan
|
|
12 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
ABSTRAL
Abstral®|Actiq®|Durogesic®|Effentora®|MCN-JR-4263-49|R-4263|Sublimaze®
ACTIQ
AD 923
AD-923
BREAKYL
Cephalon brand OF fentanyl buccal oravescent
Duragesic
DURAGESIC-100
DURAGESIC-12
DURAGESIC-25
DURAGESIC-37
DURAGESIC-50
DURAGESIC-75
Durogesic
DUROGESIC DTRANS
EFFENTORA
FENCINO
FENTALIS RESERVOIR
Fentanest
Fentanil
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl CII
Fentanyl citrate
FENTANYL-100
FENTANYL-12
FENTANYL-25
FENTANYL-37
FENTANYL-50
FENTANYL-62
FENTANYL-75
FENTANYL-87
Fentanylum
|
Fentanylum [INN-Latin]
Fentora
IDS-NF-001
INNOVAR
IONSYS
Janssen pharmaceutica brand OF fentanyl
LEPTANAL
MATRIFEN
MCN-JR-4263-49
MEZOLAR MATRIX
MYLAFENT
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N02AB03
Nasalfent
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
OPIODUR
ORALET
OSMACH
OSMANIL
PECFENT
Pentanyl
Phentanyl
R 4263
R-4263
Rapinyl
RECIVIT
Sentonil
Sublimaze
Subsys
TILOFYL
Transmucosal oral fentanyl citrate
VICTANYL
YEMEX
|
|
13 |
|
Midazolam |
Approved, Illicit |
Phase 4 |
|
59467-70-8 |
4192 |
Synonyms:
Buccolam
Buccolam®|Dormicum®|Nayzilam®|USL261 (nasal spray formulation)|Versed®
Dea no. 2884
Dormicum
Hydrochloride, midazolam
Maleate, midazolam
Mezolam
Midazolam
Midazolam base
MIDAZOLAM CIV
|
Midazolam Hcl
Midazolam hydrochloride
Midazolam maleate
Midazolamum
Midazolamum [INN-Latin]
Nayzilam
USL261
USL-261
Versed
|
|
14 |
|
Atropine |
Approved, Vet_approved |
Phase 4 |
|
101-31-5, 5908-99-6, 51-55-8 |
3661 154417 174174 |
Synonyms:
(-)-Atropine
(−)-ATROPINE
(-)-Hyoscyamine
(−)-HYOSCYAMINE
(±)-atropine
(±)-hyoscyamine
(Leo)-atropine
(Leo)-hyoscyamine
(S)-(-)-Hyoscyamine
(S)-(−)-HYOSCYAMINE
(S)-(Leo)-hyoscyamine
(S)Atropine
(S)-ATROPINE
[3(S)-endo]-a-(Hydroxymethyl)benzeneacetate 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-a-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-alpha-(Hydroxymethyl)benzeneacetate 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-Α-(hydroxymethyl)benzeneacetate 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-Α-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
Anaspaz
ATROJECT
ATROPEN
Atropen®|hyoscyamine
ATROPHATE
Atropin
Atropina
ATROPINE
ATROPINE (AUTOINJECTOR)
Atropine sulfate, 3(S)-endo-isomer
Atropine, 3(S)-endo-isomer
Atropinum
BUWECON
CYSTOSPAZ
Cytospaz
|
DATURIN
Daturine
dl-Hyoscyamine
dl-tropyltropate
DONNAMAR
Duboisine
EGAZIL
Hyocyamine
HYOMAX
HYOSCYAMIN
Hyoscyamine
Hyoscyamine hydrobromide
Hyoscyamine hydrochloride
Hyoscyamine sulfate
Hyoscyamine sulfate anhydrous
HYOSCYAMINUM
ISOPTO ATROPINE
L-Atropine
LEVBID
LEVSIN
LEVSINEX
L-Hyopscyamine
L-Hyoscamine
L-Hyoscyamine
L-Tropine tropate
L-Tropine tropic acid
NEOQUESS
NULEV
SPACOL T/S
SYMAX
Tropine tropate
Tropine, (-)-tropate
Tropine, (-)-tropic acid
TROPINE-L-TROPATE
|
|
15 |
|
Propofol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2078-54-8 |
4943 |
Synonyms:
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Diisopropylphenol
2,6-diisopropylphenol|Diprivan®|ICI 35868
Abbott brand OF propofol
Alpha Brand OF propofol
Aquafol
Astra brand OF propofol
AstraZeneca brand OF propofol
Braun brand OF propofol
Curamed brand OF propofol
Diisopropylphenol
Diprivan
Disoprivan
Disoprofol
Fresenius brand OF propofol
Fresenius kabi brand OF propofol
Fresofol
ICI 35868
ICI 35-868
|
ICI35,868
ICI-35868
Ivofol
Juste brand OF propofol
NSC-5105
Parnell brand OF propofol
Pisa brand OF propofol
Propofol
Propofol abbott
Propofol fresenius
Propofol MCT
Propofol rovi
Propofol-lipuro
Propofolum
Rapinovet
Recofol
Rovi brand OF propofol
Schering brand OF propofol
Zeneca brand OF propofol
|
|
16 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
17 |
|
Antimitotic Agents |
|
Phase 4 |
|
|
|
18 |
|
Tubulin Modulators |
|
Phase 4 |
|
|
|
19 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
20 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
21 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
22 |
|
Analgesics |
|
Phase 4 |
|
|
|
23 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
24 |
|
Ranitidine bismuth citrate |
|
Phase 4 |
|
|
|
Synonyms:
GR-122311X
PYLORID
RANITIDINE BISMUTH CITRATE
|
RANITIDINE BISMUTREX
TRITEC
|
|
25 |
|
Anesthetics |
|
Phase 4 |
|
|
|
26 |
|
Tea |
|
Phase 4 |
|
|
|
27 |
|
Plasminogen |
Approved |
Phase 3 |
|
9001-91-6 |
|
Synonyms:
1-glutamylplasminogen
Human plasminogen
Plasma trypsinogen
|
plasminogen, human-tvmh
Profibrinolysin
|
|
28 |
|
Bleomycin |
Approved, Investigational |
Phase 3 |
|
9041-93-4, 11056-06-7 |
5360373 |
Synonyms:
Almirall brand OF bleomycin sulfate
Bellon brand OF bleomycin sulfate
Bellon, bléomycine
Blanoxan
Blenoxane
Bleo
Bleo cell
Bleo-cell
BLEOcell
Bleocin
BLEO-KYOWA
Bleolem
Bleomicin
Bleomicina
Bleomicina [INN-Spanish]
Bleomycin
Bleomycin a(2)
Bleomycin a2
Bleomycin b(2)
Bleomycin b2
BLEOMYCIN HYDROCHLORIDE
|
Bleomycin sulfate
Bleomycin sulphate
Bleomycine
Bleomycine [INN-French]
Bléomycine bellon
Bleomycins
Bleomycinum
Bleomycinum [INN-Latin]
Bleomycinum mack
BLM
Bristol myers squibb brand OF bleomycin sulfate
Bristol-myers squibb brand OF bleomycin sulfate
Bull brand OF bleomycin sulfate
Cell pharm brand OF bleomycin sulfate
Lemery brand OF bleomycin sulfate
Lundbeck brand OF bleomycin sulfate
Mack brand OF bleomycin sulfate
Mack, bleomycinum
NSC-125066
Sulfate, bleomycin
|
|
29 |
|
Fibrinolytic Agents |
|
Phase 3 |
|
|
|
30 |
|
Tissue Plasminogen Activator |
|
Phase 3 |
|
|
|
31 |
|
Anti-Bacterial Agents |
|
Phase 3 |
|
|
|
32 |
|
Antibiotics, Antitubercular |
|
Phase 3 |
|
|
|
33 |
|
Sclerosing Solutions |
|
Phase 3 |
|
|
|
34 |
|
Carboplatin |
Approved |
Phase 2 |
|
41575-94-4 |
10339178 38904 |
Synonyms:
Blastocarb
Carboplat
CARBOPLATIN
Carboplatine
Carboplatino
Carbosin
Carbotec
Cbdca
CIS-(1,1-CYCLOBUTANEDICARBOXYLATO)DIAMMINEPLATINUM(II)
CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM
CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II)
|
Ercar
JM 8
JM8
JM-8
Nealorin
Neocarbo
NSC-201345
NSC-241240
PARAPLATIN
Paraplatin-AQ
Ribocarbo
|
|
35 |
|
Paclitaxel |
Approved, Vet_approved |
Phase 2 |
|
33069-62-4 |
36314 |
Synonyms:
(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7 Epi taxol
7-Epipaclitaxel
7-Epi-paclitaxel
7-epipaclitaxel|Abraxane® (albumin-bound suspension)|Taxol®
7-Epitaxol
7-Epi-taxol
ABI-007
ABRAXANE
Anzatax
BMS 181339-01
BMS-181339-01
Bris taxol
CAPXOL
CYCLOPAX
DHP 107
|
EBETAXEL
Epitaxol
GENETAXYL
GENEXOL
INTAXEL
LIPOPAC
MBT 0206
MITOTAX
NK 105
NSC-125973
Onxol
PACITAXEL
PACLITAXEL
Paclitaxel, (4 alpha)-isomer
Paxceed
Paxene
PLAXICEL
Praxel
QW-8184
TAXALBIN
TAXOL
TAXOL 100
Taxol a
Taxol, bris
Vascular Wrap
Xorane
YEWTAXAN
|
|
36 |
|
Erlotinib |
Approved, Investigational |
Phase 2 |
|
183319-69-9, 183321-74-6 |
176870 |
Synonyms:
[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine
[6,7-Bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine
11C Erlotinib
11C-Erlotinib
CP-358
CP-358,774
CP-358774
CP-35877401
CP-358774-01
ERLOTINIB
Erlotinib HCL
Erlotinib hydrochloride
Erlotinibum
|
HCL, Erlotinib
Hydrochloride, erlotinib
N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
NSC 718781
NSC 718781|OSI 744|OSI-774|R 1415|Tarceva®
OSI 744
OSI 774
OSI-774
R 1415
R-1415
RG-1415
RO-508231
Tarceva
|
|
37 |
|
Bevacizumab |
Approved, Investigational |
Phase 2 |
|
216974-75-3 |
135329020 |
Synonyms:
12-IGG1
ANTIVEGF
Anti-VEGF Humanized Monoclonal Antibody
Anti-VEGF monoclonal antibody
AVA-1
AVASTIN
Bevacizumab
BEVACIZUMAB BETA
bevacizumab-awwb
|
BI 695502
BS-503A
FKB-238
HLX04
HLX-04
R-435
RG-435
RHUMAB-
rhuMAb-VEGF
|
|
38 |
|
Albumin-Bound Paclitaxel |
|
Phase 2 |
|
|
|
39 |
|
Angiogenesis Inhibitors |
|
Phase 2 |
|
|
|
40 |
|
Antineoplastic Agents, Immunological |
|
Phase 2 |
|
|
|
41 |
|
Protein Kinase Inhibitors |
|
Phase 2 |
|
|
|
42 |
|
Trastuzumab |
Approved, Investigational |
Phase 1 |
|
180288-69-1 |
|
Synonyms:
4D5V8
ABP 980
ABP-980
ANTI HER2
D5v8|Herceptin®|R-597
DMB-3111 (TRASTUZUMAB BIOSIMILAR)
EG12014
EG-12014
HERCEPTIN
IG GAMMA-1 CHAIN C REGION
KADCYLA
|
R-597
RHUMAB HER2
SYD977
SYD-977
TRASTUZUMAB
TRASTUZUMAB BETA
trastuzumab-anns
trastuzumab-dkst
trastuzumab-dttb
trastuzumab-pkrb
trastuzumab-qyyp
|
|
43 |
|
Adjuvants, Immunologic |
|
Phase 1 |
|
|
|
44 |
|
Interleukin-12 |
|
Phase 1 |
|
|
|
45 |
|
Immunologic Factors |
|
Phase 1 |
|
|
|
46 |
|
Immunoglobulins |
|
|
|
|
|
47 |
|
Antibodies, Monoclonal |
|
|
|
|
|
48 |
|
Antibodies |
|
|
|
|
|
49 |
|
Brimonidine Tartrate |
|
|
|
70359-46-5 |
|
Synonyms:
AGN-190342LF
AGN-190342-LF
ALPHAGAN
ALPHAGAN P
BRIMONIDINE D-TARTRATE
BRIMONIDINE TARTRATE
|
BRYMONT
LUMIFY
MIRVASO
QOLIANA
UK-1430418
|
|
50 |
|
Respiratory System Agents |
|
|
|
|
|
Interventional clinical trials:
(show all 24)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion Following Catheter Ablation of Atrial Fibrillation |
Unknown status |
NCT02260206 |
Phase 4 |
Colchicine |
2 |
Atrial Fibrillation and Pericardial Drainage: Incidence of Postoperative Atrial Fibrillation According to the Type of Mediastinal Drainage Catheters |
Unknown status |
NCT02808897 |
Phase 4 |
|
3 |
the Post Operative Pericardial Effusion (POPE) Treatment Study |
Completed |
NCT00247052 |
Phase 4 |
diclofenac;matching placebo |
4 |
Cochicine Treatment for Post- Operative Pericardial Effusion: The POPE 2 Study A Multicenter, Double-blind, Randomized Trial |
Completed |
NCT01266694 |
Phase 4 |
Colchicines;Placebo |
5 |
A Comparative Study Between Thoracic Epidural Anesthesia in Non-Intubated Video-Assisted Thoracoscopes and the Conventional General Anesthesia With One Lung Ventilation |
Active, not recruiting |
NCT05077111 |
Phase 4 |
|
6 |
A Trial of Complete Percutaneous Pericardial Drainage Facilitated by Intrapericardial Alteplase Compared to Conventional Pericardiocentesis When Indicated in Adults With Large Pericardial Effusion Due to Tuberculous and Non-tuberculous Pericarditis |
Unknown status |
NCT02673879 |
Phase 3 |
|
7 |
COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial). |
Unknown status |
NCT01552187 |
Phase 3 |
Colchicine;Placebo |
8 |
A Randomized Controlled Trial to Evaluate the Efficacy of Intra-pericardial Instillation of a Sclerosing Agent After Pericardial Drainage in Patients With Malignant Pericardial Effusion Associated With Lung Cancer (JCOG9811) |
Completed |
NCT00132613 |
Phase 3 |
Pericardial instillation of bleomycin after drainage |
9 |
A Phase II Randomized Study of OSI-774 (Erlotinib) (NSC #718781) With or Without Carboplatin/Paclitaxel in Patients With Previously Untreated Adenocarcinoma of the Lung Who Never Smoked or Were Former Light Smokers |
Completed |
NCT00126581 |
Phase 2 |
Carboplatin;Erlotinib;Erlotinib Hydrochloride;Paclitaxel |
10 |
Intrapleural Bevacizumab Injection for Treating Malignant Pleural or Pericardial Effusion in Non-small Cell Lung Cancer |
Completed |
NCT02054052 |
Phase 2 |
Bevacizumab |
11 |
A Phase I/II Study to Investigate the Safety, Tolerability and Potential Activity of IPI-504 in Relapsed and / or Refractory Stage IIIb (With Malignant Pleural or Pericardial Effusion), or Stage IV NSCLC Patients |
Completed |
NCT00431015 |
Phase 1, Phase 2 |
IPI-504 |
12 |
A Phase I Trial of Herceptin and Interleukin-12 |
Completed |
NCT00004074 |
Phase 1 |
|
13 |
Diagnostic Value of Cell Block Immunohistochemistry in Effusion Cytology |
Unknown status |
NCT04279327 |
|
|
14 |
Drainage or Pericardiocentesis Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention. |
Unknown status |
NCT01665495 |
|
|
15 |
Feasibility and Accuracy of Focused Cardiac Ultrasound Using an FDA Approved Hand-held Ultrasound Device in Outpatient Setting in Our Institution. |
Completed |
NCT03887286 |
|
|
16 |
The Clinical Impact of an Aggressive Approach Towards Pleural and Pericardial Effusions Following Open Heart Surgery: a Step Towards Standard Guidelines |
Completed |
NCT02045641 |
|
|
17 |
Point-of-care Ultrasound in Finland |
Completed |
NCT03327688 |
|
|
18 |
Evaluation of Different Strategies of Pericardial Drainage After Aortic Valvular Surgery: A Prospective Randomized Trial |
Completed |
NCT00684125 |
|
|
19 |
Surgical Options for Management of Pericardial Effusion |
Completed |
NCT05061914 |
|
|
20 |
A Randomized Prospective Study of the Definitive Management of the Stable Haemopericardium Following Penetrating Cardiac Injury Utilising Subxyphoid Window and Drainage. |
Completed |
NCT00823160 |
|
|
21 |
Primary Percutaneous Pericardiotomy for Malignant Pericardial Effusion (PMAP) - A Randomized Study |
Recruiting |
NCT04472468 |
|
|
22 |
Pericardial Effusion From Acute Myocardial Infarction: Contributing Factors and Prognosis at One Year (EPERICARDIM) |
Recruiting |
NCT05146492 |
|
|
23 |
A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease |
Recruiting |
NCT04464655 |
|
|
24 |
CancerCodeTM Informed, Molecularly Targeted Therapies in Non-small Cell Lung Cancer |
Terminated |
NCT02132884 |
|
targeted therapy |
|